R&D 2nd Cell Therapy for Autoimmune Disease Summit | Download the BRAND-NEW Program 02/12/2024 - 09:00 - 04/12/2024 - 17:30 Philadelphia, PA
R&D 6th Cell Therapy Analytical Development Summit | December 3-5, 2024 | Boston, MA 03/12/2024 - 09:00 - 05/12/2024 - 17:30 Boston, MA
R&D Targeted Radiopharmaceuticals Summit EU 2024 03/12/2024 - 09:00 - 05/12/2024 - 17:30 Amsterdam, The Netherlands
R&D 2nd Covalent Drug Discovery & Development Summit 10/12/2024 - 09:00 - 12/12/2024 - 17:30 Boston, MA
R&D 4th annual Rare & Genetic Kidney Disease Drug Development Summit 10/12/2024 - 09:00 - 12/12/2024 - 17:30 Boston, MA
R&D 8th Annual Complement-Based Drug Development Summit 10/12/2024 - 09:00 - 12/12/2024 - 17:30 Boston, MA
R&D 7th RNA-Targeted Drug Discovery & Development Summit 10/12/2024 - 09:00 - 12/12/2024 - 17:30 Boston, MA
Oncology 9th Tumor Models San Francisco Summit 2025 10/12/2024 - 09:00 - 12/12/2024 - 17:30 San Francisco
R&D Returning... The 5th Operationalize Expanded Access Programs! 18/03/2025 - 09:00 - 20/03/2025 - 17:30 Boston, MA
News Sage wilts as Huntington's prospect flunks trial Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for Huntington's disease
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
